Dr. Snuffy Myers will be the principal speaker at the “Prostate Cancer Symposium” held on Monday September 24th at the Suburban Hospital at 8600 Old Georgetown Road in Bethesda, Maryland. Registration is required. Reception is at 6:30 PM followed by the presentation at 7PM. The Symposium is free as are the snacks that are served during the reception. Get more info from ProstateSymp9-2007.pdf.

The Third Annual African American Prostate Cancer Disparity Summit will be held:
September 27 & 28, 2007 at Rayburn House Office Building, Washington, DC

When Merv Griffin died on August 12, his family said on his website :

Griffin, who turned 82 on July 6th, was recently diagnosed during a routine examination with a recurrence of the prostate cancer that he had overcome more than a decade ago. Its aggressive progression to other organs was unexpected and immediate, according to his doctors at Cedars-Sinai Medical Center in Los Angeles.

The notion of a sudden fatal resurgence may mislead other men who are fighting prostate cancer.This description of Griffin as “recently diagnosed” during a “routine examination” with a recurrence of a cancer

Free Prostate Cancer Symposium on October 20, 2007 — The Methodist Hospital, Houston, Texas. Speakers are physician-scientists from The Methodist Hospital, Baylor College of Medicine and UT.  Focus is on the roles of XRT, Robotic and Laparoscopic Surgeries; Hormone Management and Alternatives to Hormone Therapy and treatments in the pipeline such as Vaccines and Gene Therapy. Save the Date!

The Annie Appleseed Project invites you to its conference on “Evidence-based Complementary and Alternative Cancer Therapies for Cancer Advocates” aka CAM for Cancer Advocates.
January 10-11, 2008 in West Palm Beach, FL

Results from a Phase 1 study of NEUVENGE, Dendreon’s candidate vaccine for breast cancer, appeared today in Journal of Clinical Oncology. Testing of Neuvenge in clinical trials runs several years behind Provenge, which is in an ongoing Phase 3 trial. Out of 18 patients with advanced breast cancer who received Neuvenge, 1 patient showed partial response for 6 months and 3 patients had stable disease lasting more than a year.

Edap TMS SA (EDAP) said it is currently conducting clinical investigations in France under an approved clinical trial combining the company’s Ablatherm-HIFU device with chemotherapy using docetaxel.

The study is a primary treatment therapy program for men suffering from clinically localized but aggressive high risk prostate cancer typically classified as stage T2c. The study began in late 2006 and the company expects to enroll up to 30 men, of which more than 10 have already been treated. More details — press release.

Merv Griffin (July 6, 1925- August 12, 2007), a pioneer in the TV entertainment industry, has died at age 82 of prostate cancer. Merv Griffin, a singer and talk show host, created the TV games Wheel of Fortune and Jeopardy. Diagnosed with prostate cancer in 1996, he was treated initially with brachytherapy therapy [see correction below].

A California court has ordered PC Spes manufacturer Dr. Sophie Chen and International Medical Research, Incorporated (doing business as BotanicLab) to pay more than $24 million to consumers who bought PC Spes between 1998 and 2002. PC Spes, a purported herbal supplement targeted at prostate cancer patients, is no longer sold in the USA but reportedly is sold in Europe and the UK from the Netherlands.

The judgment was based on evidence of intent to defraud consumers and to loot company assets to avoid restitution.

“Contrary to the IMR Defendants representations, PC Spes was not all natural, was not all herbal, was not a dietary supplement, and was in fact a very dangerous product,” said Superior Court judge John S. Meyer, who presided over the case August 6-7 in San Diego.

In an exclusive report August 10, psa-rising.com published details of the judgment and a link to the full transcript (in .pdf).